Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Total Debt (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Total Debt came in at $21.6 billion in Q2 2026, down 4.47% year-over-year from $22.6 billion in Q2 2025, and little changed quarter-over-quarter from $21.7 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Total Debt (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Total Debt across 18 years of filings, most recently posting $21.6 billion for Q2 2026.

  • In Q2 2026, Total Debt fell 4.47% year-over-year to $21.6 billion; the TTM figure through Jun 2026 stood at $21.6 billion (down 4.47% YoY), while the FY2025 annual figure was $21.0 billion, down 13.37% from the prior year.
  • Total Debt came in at $21.6 billion for Q2 2026 at Bausch Health Companies, roughly flat from $21.7 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $24.3 billion in Q4 2024 to a low of $21.0 billion in Q2 2023.
  • Average Total Debt over 5 years is $22.1 billion, with a median of $21.9 billion recorded in 2024.
  • Year-over-year, Total Debt grew 7.74% in 2023 and retreated 13.37% in 2025.
  • Over 5 years, Total Debt stood at $21.2 billion in 2022, then increased by 7.74% to $22.8 billion in 2023, then grew by 6.36% to $24.3 billion in 2024, then slipped by 13.37% to $21.0 billion in 2025, then increased by 2.69% to $21.6 billion in 2026.
  • Per Business Quant data, the three most recent Total Debt figures were $21.6 billion in Q2 2026, $21.7 billion in Q1 2026, and $21.0 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 16.59 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 13.35 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 813.33 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 2.67 Bn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 21.61 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 1.34 Bn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 301.48 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 612.05 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn -
10 RedHill Biopharma 171.02 Mn 171.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.61 Bn
Mar 31, 2026 21.65 Bn
Dec 31, 2025 21.04 Bn
Sep 30, 2025 21.62 Bn
Jun 30, 2025 22.62 Bn
Mar 31, 2025 21.79 Bn
Dec 31, 2024 24.29 Bn
Sep 30, 2024 21.96 Bn
Jun 30, 2024 22.11 Bn
Mar 31, 2024 22.61 Bn
Dec 31, 2023 22.84 Bn
Sep 30, 2023 22.97 Bn
Jun 30, 2023 21.00 Bn
Mar 31, 2023 21.10 Bn
Dec 31, 2022 21.20 Bn
Sep 30, 2022 21.63 Bn
Jun 30, 2022 21.96 Bn
Mar 31, 2022 23.17 Bn
Dec 31, 2021 22.65 Bn
Sep 30, 2021 22.36 Bn